Business Wire

Seonix Bio Announces US Launch of SightScore, the First Commercially Available Clinical Polygenic Risk Score Testing Service for Glaucoma

SAN DIEGO--(BUSINESS WIRE)--Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic ...
Fox2Now St. Louis

Galatea Bio Launches StrataRisk™ Polygenic Risk Score to Scale Common Disease Risk Assessment and Reporting at the 2025 ACMG Conference

MIAMI LAKES, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Galatea Bio, a leader in precision health, announced today the launch of StrataRisk™, a Polygenic Risk Score (PRS) Software-as-a-Service (SaaS) ...